Abdominal Sonographic Findings and Their Association With Thrombocytopenia in Dengue Fever: A Cross-Sectional Study From an Endemic Region
1 other identifier
observational
150
1 country
1
Brief Summary
Dengue fever is a common mosquito-borne viral infection in many tropical regions, including Sudan. Some patients develop severe forms of the disease, such as dengue hemorrhagic fever, which can lead to plasma leakage, bleeding, organ involvement, and life-threatening complications. Early identification of patients at risk of severe disease is essential for timely management and improved outcomes. This study aims to describe the abdominal ultrasound findings in patients diagnosed with dengue fever and to examine how these findings relate to clinical features and blood test results, particularly low platelet counts (thrombocytopenia). Ultrasound is a non-invasive and widely available imaging method that may help detect complications early and guide clinical decision-making. In this retrospective cross-sectional study, medical records and archived abdominal ultrasound images of 150 patients with laboratory-confirmed dengue infection were reviewed. The study evaluated the frequency of findings such as gallbladder wall thickening, fluid accumulation in the abdomen and chest, liver and spleen enlargement, and rare complications like internal bleeding. These imaging findings were then compared with patient demographics and laboratory results to determine their clinical significance. By identifying the most common ultrasound features and their association with disease severity, this study seeks to support the use of abdominal ultrasound as a practical tool for risk assessment and monitoring in dengue-endemic settings. The results may help clinicians recognize severe dengue earlier and improve patient management in resource-limited environments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2025
CompletedFirst Submitted
Initial submission to the registry
March 23, 2026
CompletedFirst Posted
Study publicly available on registry
June 2, 2026
CompletedJune 2, 2026
June 1, 2026
7 months
March 23, 2026
June 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation Between Platelet Count and Abdominal Ultrasonographic Findings in Patients With Dengue Infection
Correlation between platelet count (cells/µL), measured by complete blood count at hospital presentation, and the presence of abdominal ultrasonographic findings including gallbladder wall thickening (mm), ascites (present/absent), and hepatomegaly (present/absent), assessed by abdominal ultrasound at hospital presentation.
At hospital presentation/admission (retrospective data from July 2024 to February 2025).
Study Arms (1)
Dengue Patients with Abdominal Ultrasound
This cohort includes patients with laboratory-confirmed dengue infection (NS1 positive) who underwent abdominal ultrasonography during their illness. Clinical data, hematologic parameters (including platelet counts), and archived ultrasound findings were retrospectively reviewed to assess the association between sonographic features and disease severity.
Eligibility Criteria
The study population consisted of patients with confirmed dengue infection who presented to healthcare facilities in Kassala, Sudan, between July 2024 and February 2025. All included patients had undergone abdominal ultrasonography as part of their clinical evaluation. Demographic, clinical, laboratory, and imaging data were retrospectively collected and analyzed to assess the relationship between ultrasound findings and disease severity.
You may qualify if:
- Patients with laboratory-confirmed dengue infection (NS1 positive)
- Patients who underwent abdominal ultrasonography during the course of illness
- Availability of complete clinical, laboratory (including platelet count), and ultrasound data
- Patients of all age groups and both sexes
You may not qualify if:
- Patients without confirmed dengue diagnosis
- Patients with incomplete or missing clinical, laboratory, or ultrasound records
- Patients with pre-existing hepatic, hematologic, or abdominal conditions that may affect ultrasound findings (e.g., chronic liver disease, malignancy)
- Poor-quality or non-interpretable ultrasound images
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kassala Advanced Diagnostic Center
Kassala, Sudan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohammed Ganim
National Center for Gastrointestinal And Liver Diseases
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 23, 2026
First Posted
June 2, 2026
Study Start
July 1, 2024
Primary Completion
February 1, 2025
Study Completion
February 1, 2025
Last Updated
June 2, 2026
Record last verified: 2026-06